Skip to content
value.today

Applied Therapeutics Inc.

🇺🇸 New York, New York, USAHealth CareFounded 2016
Total raised
$183 M
5 rounds on record
Latest round
$100 M
Feb 2024
First round on record
Jan 2017
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Applied Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2024$100 MNo. 5$50 to $250 million

Applied Therapeutics Inc.: Raise no. 5, Feb 2024

Investors in this round

31 investors had bought by the notice of Mar 13, 2024: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$100 M of $100 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$7,499,850
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Hansard · Executive Officer · Chief Commercial Officer
  • Catherine Thorpe · Executive Officer · Chief Accounting Officer
  • Les Funtleyder · Executive Officer, Director · Chief Financial Officer and Director
  • Riccardo Perfetti · Executive Officer · Chief Medical Officer
  • Shoshana Shendelman · Executive Officer, Director · President and Chief Executive Officer
  • Jay S. Skyler · Director
  • Joel S. Marcus · Director
  • Stacy J. Kanter · Director
  • Teena J. Lerner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Robert W. Baird & Co. Inc. (CRD 8158) · Milwaukee, WisconsinSold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT
  • RBC Capital Markets, LLC (CRD 31194) · New York, New YorkSold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT
  • Leerink Partners LLC (CRD 39011) · Boston, MassachusettsSold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT
  • UBS Securities LLC (CRD 7654) · New York, New YorkSold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT

Signed by Shoshana Shendelman, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 13, 2024. Read the notice at the SEC.

equity, optionsSEC
Apr 2023$30 MNo. 4$10 to $50 million

Applied Therapeutics Inc.: Raise no. 4, Apr 2023

Investors in this round

19 investors had bought by the notice of May 5, 2023: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,100,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Hansard · Executive Officer · Chief Commercial Officer
  • Riccardo Perfetti · Executive Officer · Chief Medical Officer
  • Shoshana Shendelman · Executive Officer, Director · President, CEO and Chair of the Board of Directors
  • Jay S. Skyler · Director
  • Joel S. Marcus · Director
  • Les Funtleyder · Director
  • Stacy J. Kanter · Director
  • Teena J. Lerner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • UBS Securities LLC (CRD 7654) · New York, New YorkSold in CA, IL, MA, MD, NY
  • SVB Securities LLC (CRD 39011) · New York, New YorkSold in CA, IL, MA, MD, NY

Signed by Shoshana Shendelman, Chief Executive Officer. Source: SEC Form D, newest notice filed May 5, 2023. Read the notice at the SEC.

equity, optionsSEC
Nov 2019$20 MNo. 3$10 to $50 million

Applied Therapeutics Inc.: Raise no. 3, Nov 2019

Investors in this round

12 investors had bought by the notice of Nov 21, 2019: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,250,449
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Vignola · Executive Officer · Chief Financial Officer
  • Riccardo Perfetti · Executive Officer · Chief Medical Officer
  • Shoshana Shendelman · Executive Officer, Director · President, CEO and Chair of the Board of Directors
  • Jay S. Skyler · Director
  • Joel S. Marcus · Director
  • Les Funtleyder · Director
  • Stacy J. Kanter · Director
  • Teena J. Lerner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • UBS Securities LLC · New York, New YorkSold in CA, IL, MA, NY, VA
  • John Dexter Pearson (CRD 6093501) · broker-dealer Collage Partners, a division of CIM Securities LLC (CRD 120852) · New York, New YorkSold in CA, IL, NY, TX, VA
  • Cowen and Company, LLC · New York, New YorkSold in CA, IL, MA, NY, VA

Signed by Mark Vignola, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 21, 2019. Read the notice at the SEC.

equitySEC
Nov 2018$27 MNo. 2$10 to $50 million

Applied Therapeutics Inc.: Raise no. 2, Nov 2018

Investors in this round

37 investors had bought by the notice of Nov 19, 2018: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$27 M of $57 M offered; $29 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$521,713
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Shoshana Shendelman · Executive Officer, Director
  • Franklin Berger · Director
  • Joel Marcus · Director
  • Les Funtleyder · Director
  • Teena Lerner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • CIM Securities, LLC (CRD 120852) · New York, New YorkSold in CA, CO, CT, FL, MI, NJ, NV, NY, OH, TX, WY

Signed by Shoshana Shendelman, President and Secretary. Source: SEC Form D, newest notice filed Nov 19, 2018. Read the notice at the SEC.

equity, optionsSEC
Jan 2017$6 MNo. 1$2 to $10 million

Applied Therapeutics Inc.: Raise no. 1, Jan 2017

Investors in this round

26 investors had bought by the notice of Feb 8, 2017: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $7 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$560,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Shoshana Shendelman · Executive Officer, Director
  • Les Funtleyder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Brookline Capital Market (CRD 120852) · broker-dealer a division of CIM Securities, LLC (CRD 120852) · New York, New YorkSold in AL, CA, CO, CT, FL, IL, MI, MS, NJ, NY, TX, WI, WY

Remarks in the notice

  • On fees: “$490,000 reflects the cash sales commission to a broker and $70,000 reflects the value of the discount the broker receives when purchasing shares.”
  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits in the ordinary course, no persons required to be named as executive officers, directors or promoters in response to Item 3 will receive any payment from the proceeds of this offering.”

Signed by Shoshana Shendelman, President and Secretary. Source: SEC Form D, newest notice filed Feb 8, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Applied Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2024).

    SEC Form D · Mar 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2024

That is all the official record says: Applied Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

5 named in official filings. Open an investor to see everything it has backed.

Investors in Applied Therapeutics Inc.
InvestorKindAmountRoundRoleSource
Alexandria Real Estate Equities IncCompanynot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Alexandria Venture Investments, LLCVenture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Joel S. MarcusPersonnot statednot statedHeld Series A and B preferred stock, director (Form 3, 2019)SEC Form 3
Leslie D. FuntleyderPersonnot statednot statedHeld Series A and B preferred stock, director (Form 3, 2019)SEC Form 3
Teena LernerPersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2019)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 37 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Applied Therapeutics Inc.
NameRoleNamed in
Adam HansardChief Commercial OfficerMar 2024
Catherine ThorpeChief Accounting OfficerMar 2024
Les FuntleyderChief Financial Officer and DirectorMar 2024
Riccardo PerfettiChief Medical OfficerMar 2024
Shoshana ShendelmanPresident and Chief Executive OfficerMar 2024
Mark VignolaChief Financial OfficerNov 2019
Jay S. SkylerDirectorMar 2024
Joel S. MarcusDirectorMar 2024
Les FuntleyderChief Financial Officer and DirectorMar 2024
Shoshana ShendelmanPresident and Chief Executive OfficerMar 2024
Stacy J. KanterDirectorMar 2024
Teena J. LernerDirectorMar 2024
Franklin BergerDirectorNov 2018
Joel MarcusDirectorNov 2018
Teena LernerDirectorNov 2018